PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 254 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $280,089 | -51.1% | 6,990 | -28.9% | 0.02% | +12.5% |
| Q2 2022 | $573,000 | +2.1% | 9,837 | +33.9% | 0.02% | 0.0% |
| Q1 2022 | $561,000 | -21.2% | 7,346 | -37.9% | 0.02% | -11.1% |
| Q4 2021 | $712,000 | -12.2% | 11,827 | -23.4% | 0.02% | -60.0% |
| Q2 2020 | $811,000 | +95.4% | 15,447 | +24.7% | 0.04% | +60.7% |
| Q1 2020 | $415,000 | +66.0% | 12,389 | +124.7% | 0.03% | +180.0% |
| Q4 2019 | $250,000 | -24.2% | 5,514 | -36.4% | 0.01% | -33.3% |
| Q3 2019 | $330,000 | -56.2% | 8,674 | -49.9% | 0.02% | -59.5% |
| Q2 2019 | $754,000 | +9325.0% | 17,327 | +8311.2% | 0.04% | – |
| Q1 2019 | $8,000 | -89.3% | 206 | -89.7% | 0.00% | -100.0% |
| Q3 2017 | $75,000 | -34.2% | 2,000 | -20.0% | 0.01% | -36.4% |
| Q1 2017 | $114,000 | -85.6% | 2,500 | -89.2% | 0.01% | -86.7% |
| Q3 2016 | $794,000 | +1935.9% | 23,200 | +1928.0% | 0.08% | +1560.0% |
| Q2 2016 | $39,000 | -64.9% | 1,144 | -45.4% | 0.01% | -66.7% |
| Q1 2016 | $111,000 | -56.6% | 2,094 | -37.2% | 0.02% | -62.5% |
| Q4 2015 | $256,000 | +848.1% | 3,333 | +1011.0% | 0.04% | +900.0% |
| Q4 2014 | $27,000 | -87.6% | 300 | -86.7% | 0.00% | -87.1% |
| Q3 2014 | $218,000 | +2322.2% | 2,250 | +2150.0% | 0.03% | +3000.0% |
| Q2 2014 | $9,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |